Amit Sachdev, EVP Chief Patient & Ext Af Off: Vertex Pharmaceuticals VRTX Sell · Filed 02/23

Trade details

Type: Insider sale
Amount: $5,510,964.48
Shares · price: 11,712 sh · $470.54 a share
Held after: 63,171 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Amit SachdevEVP Chief Patient & Ext Af Off
Trade date: 26/02/19
Filed: 26/02/23
Days to filing: 4 days

Sold 15.6% of holdings

Share of holding sold: 15.6%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/20~03/21

Amit Sachdev's recent trades

Amit SachdevEVP Chief Patient & Ext Af Off
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$897.8K
1,846 sh
$897.8K
Filed 02/26
Traded 02/25
Amit SachdevEVP Chief Patient & Ext Af Off
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$897.8K
1,846 sh
$897.8K
Filed 02/25
Traded 02/25
Amit SachdevEVP Chief Patient & Ext Af Off
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$9.2M
19,662 sh
$9.2M
Filed 02/23
Traded 02/19
Amit SachdevEVP Chief Patient & Ext Af Off
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$4.8M
10,263 sh
$4.8M
Filed 02/23
Traded 02/19
Amit SachdevEVP Chief Patient & Ext Af Off
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$3.4M
7,241 sh
$3.4M
Filed 02/23
Traded 02/19

Amit Sachdev, Chief Officer — sold $5.5M of Vertex Pharmaceuticals VRTX · 15.6% of holdings · 10b5-1 plan | Whalegun